Cancers, Vol. 15, Pages 3739: The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma

Cancers, Vol. 15, Pages 3739: The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma Cancers doi: 10.3390/cancers15143739 Authors: Moloud Sooreshjani Shashwat Tripathi Corey Dussold Hinda Najem John de Groot Rimas V. Lukas Amy B. Heimberger Cytokines play an important role in regulating the immune response. Although there is great interest in exploiting cytokines for cancer immunotherapy, their clinical potential is limited by their pleiotropic properties and instability. A variety of cancer cell-intrinsic and extrinsic characteristics pose a barrier to effective treatments including cytokines. Recent studies using gene and cell therapy offer new opportunities for targeting cytokines or their receptors, demonstrating that they are actionable targets. Current efforts such as virotherapy, systemic cytokine therapy, and cellular and gene therapy have provided novel strategies that incorporate cytokines as potential therapeutic strategies for glioblastoma. Ongoing research on characterizing the tumor microenvironment will be informative for prioritization and combinatorial strategies of cytokines for future clinical trials. Unique therapeutic opportunities exist at the convergence of cytokines that play a dual role in tumorigenesis and immune modulation. Here, we discuss the underlying strategies in pre- and clinical trials aiming to enhance treatment outcomes in glioblastoma patients.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research